Johnson & Johnson's anaemia treatment Procrit (epoetin alfa) is more effective at boosting red blood cells in patients undergoing cancer chemotherapy than rival drug Aranesp (darbepoetin alfa) from ...

Amgen and Centocor Ortho Biotech announced a voluntary nationwide recall of certain lots of Epogen (epoetin alfa) and Procrit (epoetin alfa) vials that may contain extremely thin glass flakes ...

After a couple of misfires, Pfizer has finally won FDA approval for its biosimilar of anemia drug Epogen/Procrit, a drug whose U.S. sales generated about $1.8 billion last year for partners Amgen and ...

Dec. 2, 2005 -- The US Food and Drug Administration (FDA), Amgen Inc, and Ortho Biotech Clinical Affairs, LLC, have notified healthcare professionals via letter regarding revisions to the safety ...

Products were found to contain thin glass flakes, but their potential to impact patients is expected to be low. Amgen has voluntarily recalled certain lots of Epogen® and Procrit® (epoetin alfa) vials ...

Epoetin alfa 10000 Units, 20000 Units; per mL; soln for IV or SC inj; contains albumin (human) and benzyl alcohol. Individualize (see full labeling for titration). CKD: initially 50–100 Units/kg 3 ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Amgen Inc. and Johnson & Johnson recalled certain lots of the anemia drugs Epogen and Procrit that may be contaminated with glass shards that flake off vials into the medicines. The “extremely thin ...

The whistleblower pharmaceutical sales reps in the Procrit case reinstated in a Massachussetts federal court claim that their careers at Johnson & Johnson's Ortho Biotech unit were based mostly on ...

Journalist Kathleen Sharp's "Blood Feud" opens with a horrific scene. Jim Lenox, a 54-year-old cancer patient, home recuperating after chemotherapy treatments, is feeling hopeful. Suddenly, rivers of ...

The US Food and Drug Administration (FDA) has approved the first biosimilar erythropoiesis-stimulating agent. The reference product is epoetin alfa (Epogen/Procrit, Amgen). The new biosimilar is ...

THOUSAND OAKS, Calif., Sept. 24 /PRNewswire/ -- Amgen (Nasdaq: AMGN) announced today that certain lots of EPOGEN® and PROCRIT® (Epoetin alfa) vials are being voluntarily recalled from specialty ...